TimeScale Financial’s Takeda Pharmaceutical TAK Stock Holding History

TimeScale Financial’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$3.24K	Hold	206	–	–	﹤0.01%	477
2023 Q1	$3.4K	Hold	206	–	–	﹤0.01%	455
2022 Q4	$2.67K	Hold	206	–	–	﹤0.01%	440
2022 Q3	$3K	Hold	206	–	–	﹤0.01%	438
2022 Q2	$3K	Hold	206	–	–	﹤0.01%	416
2022 Q1	$3K	Hold	206	–	–	﹤0.01%	426
2021 Q4	$3K	Hold	206	–	–	﹤0.01%	423
2021 Q3	$3K	Hold	206	–	–	﹤0.01%	419
2021 Q2	$3K	Hold	206	–	–	﹤0.01%	421
2021 Q1	$4K	Hold	206	–	–	﹤0.01%	409
2020 Q4	$4K	Hold	206	–	–	﹤0.01%	359
2020 Q3	$4K	Hold	206	–	–	﹤0.01%	374
2020 Q2	$4K	Hold	206	–	–	﹤0.01%	366
2020 Q1	$3K	Hold	206	–	–	﹤0.01%	362
2019 Q4	$4K	Hold	206	–	–	﹤0.01%	449
2019 Q3	$4K	Hold	206	–	–	﹤0.01%	422
2019 Q2	$4K	Buy	+206	New	+$3.75K	﹤0.01%	437

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TimeScale Financial's TAK Position: Q2 2023 in Review

TimeScale Financial held its Takeda Pharmaceutical (TAK) position steady in Q2 2023 at 206 shares worth $3.24K. The position accounts for ﹤0.01% of the portfolio, ranked #477.

TimeScale Financial first reported a position in TAK in Q2 2019 and has held it in 17 quarters since. The position peaked at $4K in Q1 2021. 310 funds tracked by Wall St. Rank hold TAK as of Q2 2023.

TimeScale Financial held 206 shares of Takeda Pharmaceutical worth $3.24K as of Q2 2023.
TimeScale Financial left its Takeda Pharmaceutical share count unchanged in Q2 2023.
Takeda Pharmaceutical made up ﹤0.01% of TimeScale Financial's portfolio in Q2 2023, its #477 holding.
TimeScale Financial first reported a position in Takeda Pharmaceutical in Q2 2019 and has held it in 17 quarters since.
TimeScale Financial's Takeda Pharmaceutical position peaked at $4K in Q1 2021.
310 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.